14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EDGE ranks #14713 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Edge Therapeutics Stock Forecast NASDAQ:EDGE

$9.71 (4.97%)

Volume: 248k

Closed: Dec 08, 2021

Hollow Logo Score: -2.006

Edge Therapeutics Stock Forecast

$9.71 (4.97%)

Volume: 248k

Closed: Dec 08, 2021

Score Hollow Logo -2.006

EDGE Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -40.67% during the next 3 months and, with a 90% probability hold a price between $4.79 and $6.43 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-12-10 $7.95 $9.33 $10.71
2021-12-13 $7.83 $9.21 $10.60
2021-12-14 $7.71 $9.10 $10.48
2021-12-15 $7.59 $8.98 $10.36
2021-12-16 $7.48 $8.86 $10.24
2021-12-17 $7.36 $8.74 $10.13
2021-12-20 $7.24 $8.62 $10.01
2021-12-21 $7.12 $8.51 $9.89
2021-12-22 $7.01 $8.39 $9.77
2021-12-23 $6.89 $8.27 $9.65
2021-12-27 $6.77 $8.15 $9.54
2021-12-28 $6.65 $8.03 $9.42
2021-12-29 $6.53 $7.92 $9.30
2021-12-30 $6.42 $7.80 $9.18
2021-12-31 $6.30 $7.68 $9.06
2022-01-03 $6.18 $7.56 $8.95
2022-01-04 $6.06 $7.45 $8.83
2022-01-05 $5.94 $7.33 $8.71
2022-01-06 $5.83 $7.21 $8.59
2022-01-07 $5.71 $7.09 $8.47
2022-01-10 $5.59 $6.97 $8.36
2022-01-11 $5.47 $6.86 $8.24
2022-01-12 $5.36 $6.74 $8.12
2022-01-13 $5.24 $6.62 $8.00
2022-01-14 $5.12 $6.50 $7.89
2022-01-17 $5.00 $6.38 $7.77
2022-01-18 $4.88 $6.27 $7.65
2022-01-19 $4.77 $6.15 $7.53
2022-01-20 $4.65 $6.03 $7.41
2022-01-21 $4.53 $5.91 $7.30

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT